Litcius/Paper detail

Epithelial cell dysfunction in chronic rhinosinusitis: the epithelial–mesenchymal transition

Jing Yuan, Ming Wang, Chengshuo Wang, Luo Zhang

2023Expert Review of Clinical Immunology19 citationsDOI

Abstract

INTRODUCTION: Epithelial-mesenchymal transition (EMT) is a type of epithelial cell dysfunction, which is widely present in the nasal mucosa of patients with chronic rhinosinusitis (CRS), especially CRS with nasal polyps, and contributes to pathogenesis of the disease. EMT is mediated via complex mechanisms associated with multiple signaling pathways. AREAS COVERED: We have summarized the underlying mechanisms and signaling pathways promoting EMT in CRS. Strategies or drugs/agents targeting the genes and pathways related to the regulation of EMT are also discussed for their potential use in the treatment of CRS and asthma. A literature search of studies published in English from 2000 to 2023 was conducted using the PubMed database, employing CRS, EMT, signaling, mechanisms, targeting agents/drugs, as individual or combinations of search terms. EXPERT OPINION: EMT in nasal epithelium not only leads to epithelial cell dysfunction but also plays an important role in nasal tissue remodeling in CRS. A comprehensive understanding of the mechanisms underlying EMT and the development of drugs/agents targeting these mechanisms may provide new treatment strategies for CRS.

Topics & Concepts

Epithelial–mesenchymal transitionMedicineNasal polypsChronic rhinosinusitisSignal transductionPathogenesisMesenchymal stem cellDiseaseCellBioinformaticsCancer researchImmunologyPathologyBiologyCancerMetastasisInternal medicineCell biologyGeneticsSinusitis and nasal conditionsCystic Fibrosis Research AdvancesInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Epithelial cell dysfunction in chronic rhinosinusitis: the epithelial–mesenchymal transition | Litcius